TY - BOOK ID - 134501277 TI - Guidance for industry : new contrast imaging indication considerations for devices and approved drug and biological products. AU - United States. AU - Center for Devices and Radiological Health (U.S.) AU - Center for Drug Evaluation and Research (U.S.) PY - 2008 PB - Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Office of Combination Products (OCP) in Office of Commissioner : Center for Devices and Radiological Health (CDRH) : Center for Drug Evaluation and Research (CDER), DB - UniCat KW - Contrast-enhanced magnetic resonance imaging KW - Contrast-enhanced ultrasound KW - Biomedical materials KW - Equipment and supplies KW - Evaluation. KW - Equipment and supplies KW - Evaluation. KW - Evaluation. UR - https://www.unicat.be/uniCat?func=search&query=sysid:134501277 AB - ER -